ENTA SBC to Revenue
Enanta Pharmaceuticals Inc · SBC to Revenue
ENTA SBC to Revenue
Latest reported25.65%period ending
ENTA Quarterly SBC/Revenue (0.00% → 25.65%)
Latest values, visible window
High-resolution chart · PNG
ENTA sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 25.6494% | |
| 21.8428% | |
| 20.4674% | |
| 26.6711% | |
| 22.8077% | |
| 31.4083% | |
| 33.41% | |
| 52.8377% | |
| 30.143% | |
| 32.6082% | |
| 44.9869% | |
| 35.4743% | |
| 37.0421% | |
| 41.3768% | |
| 30.2692% | |
| 33.6319% | |
| 39.0318% | |
| 34.5747% | |
| 21.9256% | |
| 22.7063% | |
| 25.3191% | |
| 26.2269% | |
| 15.3829% | |
| 20.0796% | |
| 25.4865% | |
| 18.0238% | |
| 9.6975% | |
| 8.7931% | |
| 9.3854% | |
| 11.8771% | |
| 8.3608% | |
| 6.1156% | |
| 7.0291% | |
| 8.15% | |
| 10.8111% | |
| 4.2277% | |
| 41.2994% | |
| 38.9776% | |
| 31.3622% | |
| 19.5468% | |
| 17.6706% | |
| 18.3174% | |
| 4.1119% | |
| 12.4653% | |
| 13.6563% | |
| 2.491% | |
| 1.3265% | |
| 30.1479% | |
| 1.8454% | |
| 34.8148% | |
| 40.2016% | |
| 21.2009% | |
| 14.4936% | |
| 21.4883% | |
| 1.0087% | |
| 13.0786% | |
| 3.7372% | |
| 0.0848% | |
| 7.4224% | |
| 0% |